Northern Light Venture Capital

Northern Light Venture Capital, founded in 2005 by Feng Deng and Yan Ke, is a China-focused venture capital firm that manages approximately $1.5 billion in committed capital across multiple funds. With a team of five Managing Directors, it has invested in over 180 portfolio companies, primarily targeting early and growth stage opportunities in sectors such as information technology, new media, clean technologies, consumer services, and healthcare. The firm is distinguished by its partnership of experienced local Chinese and returnee executives, who have significant backgrounds in investing and entrepreneurship. Notable portfolio companies include Meituan.com, Kaixin001.com, and Gogo.com. Northern Light Venture Capital aims to leverage China's industrial and economic resources to foster innovative and disruptive business ventures that can thrive in the global market.

Xin Chen

VP

Yan Ke

Venture Partner and Co-Founder

Dongxun Lee

MD and CFO

Lixin Li

Managing Director

Stella Li

Partner

Lu Lin

Executive Director

Han Shen

VP

Simon Sun

Venture Partner

Zhi Tan

Venture Partner

Huahua Yao

Associate

Fiona Yu

Vice President

Figo Zhang

Partner

Simon Zhao

Vice President

400 past transactions

ECTEK

Post in 2023
Changzhou ECTEK Automotive Systems CO., Ltd researches, develops, manufactures, and sells electrical automotive products. The company offers vehicle control systems, test bench and control systems, electronic control unit (ECU) test systems, and diesel electric control systems. Changzhou ECTEK Automotive Systems CO., Ltd supplies its products to marine, locomotive, construction machinery, and other power industries. The company was founded in 2005 and is based in Changzhou, China.

Surpath

Seed Round in 2022
Surpath is an AI-driven cloud-based platform that formulates optimal supply chain solutions based on clients' needs. The firm provides cross-border transportation to destination services, optimized logistics, and analytics solutions that solve complex problems.

Point One

Series B in 2022
Building the next-gen consumer products!

BUD

Series B in 2022
Founded in 2019 by former Snap engineers, Risa Feng and Shawn Lin, Singapore-headquartered BUD is a leading global metaverse UGC platform encouraging users to create and share 3D interactive experiences with its easy-to-use creation tools. Since its global launch in November 2021, BUD skyrocketed to the list of top 10 social apps in more than 38 countries around the world including North America, Southeast Asia and South America. Millions of 3D content has been created and traded on the platform. BUD has become a digital social hub where millions of people come to create, play and hangout.

Jingwei Shida

Series A in 2022
Jingwei Shida is a medical equipment R&D and supplier, focusing on the research and development of optoelectronic medical equipment.

CSR Biotech

Seed Round in 2022
Guangzhou Chaoshiji Biotechnology Co., Ltd. (Chaoshiji Technologies) is a high-tech company specializing in the creation and deployment of super-resolution imaging devices for living cells. R&D, production, sales, after-sales, and technical output services for various types of super-resolution optical microscopes are the primary activities. Among the services offered are customized cell sample generation, customized cell sample high-throughput detection, customized cell sample imaging studies, and customized image post-processing and quantitative analysis.

Huahuixin Group

Series B in 2022
"Huahuixin" was established in 2017. Its core capabilities are the design, development and production of micro-nano structured optical chips and laser chips, which are in the upstream chip manufacturing link of the optoelectronics industry. There are two main business models: on the one hand, relying on high-end optoelectronic chip technology capabilities to provide joint R&D and foundry services for optoelectronic chip design companies; on the other hand, based on the team's technical capabilities in micro-nano structured optical chips and laser chips, Independent research and development, design and large-scale production of optoelectronic products.

Zhonghui Laser

Series A in 2022
Zhonghui Laser is an emerging technology company dedicated to the development and manufacture of advanced lasers.

Xinrui Medical

Angel Round in 2022
Xinrui Medical is a domestic enterprise that engages in the research and development of polymer valves. It focuses on new polymer valves to build a complete solution for heart valve disease. The team members have long been engaged in the research and development of polymer synthesis and polymer-related medical devices. They are all from well-known medical device companies and have complete product development experience and mature industrialization thinking.

Xmov

Series C in 2022
Xmov is an AI company focusing on computer vision and computer graphics.

Binance.US

Seed Round in 2022
Binance.US provides a regulated marketplace built on cutting-edge technology for everyday access to digital assets. Their vision is to accelerate America’s transition to a digital era. It is FinCEN regulated entity in the United States. It is a cryptocurrency exchange that provides a platform for trading various cryptocurrencies.

Nanovision Technology

Venture Round in 2022
Nanovision Technology is located in Zhongguancun Yongfeng high-tech industrial base, with thousands of square meters of R&D foundation in Yonyou Industrial Park. We also set up a subsidiary company in Chengdu. their company is a high-tech enterprise focused on high-speed and high-precision radiology imaging.Nanovison focus in static CT,x-ray CMOS detectors and x-ray imaging software, etc.Which can be widely used in medical, industrial, security and other fields.

Yudao Bio

Series A in 2022
Shanghai Yudao Biotechnology Co., Ltd. engages in development of platform for drug development and medical bioinformatics trainings. The company was founded in 2013 and is based in Shanghai, China.

HemaCell

Seed Round in 2022
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish a platform using platelet cells as a drug delivery carrier.

Ucello Therapeutics

Series A in 2022
Ucello Therapeutics focuses on the development of allogeneic cell therapies utilizing its proprietary CAR-T cell technology platform, known as CBT-X20. The company aims to create universal CAR-T cell therapeutic drugs that address unmet clinical needs in cancer treatment. By leveraging advanced gene and cell therapy technologies, Ucello's therapies target cancer cells at the molecular level, making them accessible to patients with varying lymphocyte levels and those with a history of transplant relapse. This innovative approach allows for effective cancer gene therapies to be administered to individuals with specific pre-existing medical conditions.

Mindfront Health

Seed Round in 2022
Mindfront Health is a mental health company based in Shanghai, China, specializing in comprehensive diagnosis and treatment through evidence-based psychotherapy services. Established in 2020 as a brand under Luye Life Sciences Group, Mindfront Health operates a chain of psychiatric facilities across major cities, including Shanghai, Shenzhen, Guangzhou, and Xi'an. The company employs a dual approach that combines evidence-based drug treatments with non-drug interventions, aimed at addressing various mental health issues such as depression, sleep disorders, ADHD, and gaming addiction. Mindfront Health is committed to creating personalized treatment systems that cater specifically to the needs of the Chinese population, and it also offers an internet medical service platform to enhance accessibility. Through strategic collaborations with local institutions and leveraging Luye's clinical services, Mindfront Health aims to replicate its model at scale, providing holistic mental health solutions to its patients.

CATUG Biotechnology

Venture Round in 2022
CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.

H-CHIP TECH

Venture Round in 2022
H-CHIP TECH is a high-end optoelectronic research and development company based in Tianjin, China. It focuses on the development of micro-nano optoelectronic chips for industrial clients, particularly in the realm of distributed feedback (DFB) semiconductors. The company's expertise lies in creating advanced optoelectronic chips that provide reliable technological support for the optical communication industry, catering to the growing demand for innovative solutions in this field.

OUTPUT

Venture Round in 2022
OUTPUT is a creative platform for the innovation of digital experiences. It features cutting-edge digital artists, designers, and developers across the globe, initiating cross-industrial practices online and offline, updating multi-dimensional experiences generated by digital art and design, and nurturing a central hub for generative dialogues via digital experiences.

Wancheng Gene

Series A in 2021
Wancheng Gene is a single-cell gene detection platform, which is mainly used to serve the scientific research, clinical and industrial markets with a self-developed high-throughput single-cell sequencing technology platform. The existing services of Wancheng Gene include sample preparation, database sequencing, analysis, and sample processing. They can be freely combined according to customer needs, and provide peripheral services such as sample preparation training and biometric analysis.

Kind Pharmaceutical

Series B in 2021
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs. The company was founded in 2013 and is headquartered in Redwood City, California, United States.

Stellar Cyber

Series B in 2021
Stellar Cyber is an automated detection and response (Open-XDR) platform that correlates detections from existing solutions as well as its own security applications to deliver comprehensive protection across the cybersecurity kill chain and present them through one intuitive dashboard. Customers can leverage 20 native applications and a growing list of open ecosystem partners to detect and respond automatically to attacks within seconds wherever they occur on servers, in the network, at endpoints, or in cloud-based applications. Stellar Cyber deploys easily on premises, in public clouds or with service providers.

Novlead Biotech

Series B in 2021
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.

TenaFe

Series B in 2021
TenaFe is a solid-state storage controller startup that develops revolutionary SSD for data storage solutions. Its patented technology, is transforming next generation solutions by powering unparalleled reliability, performance, and energy-efficient SSDs for a wide range of devices from connected gadgets to personal computers to data centers. TeneFe was founded in 2019 and is based in Campbell, CA.
It provides mobile enterprise resource planning(ERP) systems for sales, production and storage management.

HC Scientific

Series B in 2021
HC Scientific Technology Co., Ltd. is a company based in Chengdu, China, that specializes in the development, manufacturing, and distribution of genetic testing instruments, reagents, and software. Founded in 2015, the company serves various sectors, including clinical molecular diagnostics, health genetic testing, and agricultural molecular breeding, both domestically and internationally. HC Scientific's product lineup features instruments such as the Matrix Arrayer for reaction plate preparation, the Matrix Cycler for thermal cycling, and the Matrix Scanner for fluorescence detection. Additionally, the company provides consumables like the Matrix plate and Matrix Mix genotyping reagents, along with a data management system known as Matrix Master. Committed to innovation, HC Scientific focuses on autonomous research and development of its intellectual property, aiming to deliver high-throughput, automated, and cost-effective genetic testing solutions.

Bombax

Series A in 2021
Xiaoice is an AI company that develops a chatbot that acts as a digital assistant with the capability to understand human conversations. Xiaoice allows cross-platform interactions, enabling users to enjoy the convenience of artificial intelligence. Xiaoice is designed as a teenage girl and is touted as an empathic computing framework focusing on longer back-and-forth conversations with humans instead of simply answering questions or obeying commands like most bots. Its technology covers natural language processing, computer voice, computer vision, and AI content generation.

Micot

Series B in 2021
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
OmniSensing Photonics Technology is committed to developing high-end LiDAR technology based on photonics integrated circuits (PIC) and coherent communication to subvert traditional industrial 3D technologies

Speedaf Express

Series A in 2021
Speedaf Logistics Limited provides logistics and transportation services through air, sea, and road. It provides warehousing, packaging, and labeling services. The company also provides order information and online tracking services through its platform. The company was founded in 2019 and is based in Shenzhen, China. It has additional offices in Ghana, Nigeria, Kenya, and Uganda.

LuxCreo

Series B in 2021
Founded in 2016, LuxCreo is dedicated to large-scare 3D-printing manufacturing, covering software, hardware and materials.3D printing, often referred to as additive manufacturing, a process of building a 3-dimensional object by adding material layer by layer from a computer-aided design (CAD) model, has been a buzzword globally since 2011.

Next Generation Gene Therapeutics

Series A in 2021
Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world. NGGT was founded in March 2020 by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.

InnoStar Semiconductor

Seed Round in 2021
InnoStar Semiconductor is a semiconductor storage technology service company.

Brattea

Series B in 2021
Brattea is a medical device research and development company. Brattea focuses on the development and commercialization of renal denervation products with indications in hypertension, cancer pain and diabetes.

Immune-Onc Therapeutics

Series B in 2021
Immune-Onc Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Palo Alto, California, founded in 2016. The company specializes in the discovery and development of innovative biologic therapies aimed at treating cancer. Immune-Onc Therapeutics focuses on the tumor microenvironment and immune suppressive pathways, utilizing advanced scientific insights to create novel immuno-oncology products. The company employs a targeted approach to develop first-in-class therapeutic antibodies that disarm immune suppression in tumors, thereby enhancing the immune response against cancer. Through its differentiated pipeline, Immune-Onc Therapeutics aims to provide new treatment options for cancer patients, addressing critical needs in the field of immunology and oncology.

MediTrust Health

Series B in 2021
Shanghai MediTrust Health Technology Co., Ltd. provides help to patients solve its medical expenses through financial insurance. The firm is based in Shanghai, China.

Minayo

Seed Round in 2021
Minayo is a food company that manufactures and distributes health supplements and functional snacks.

Teon Therapeutics

Series A in 2021
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways in the tumor microenvironment. Teon's lead program is an A2BR-specific antagonist that will enter Phase1b trials in 2021.

Singular Medical

Series B in 2021
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.

Neurophth

Series B in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

MagAssist

Series B in 2021
Suzhou MagAssist Medical Technology Co., Ltd. develops short and medium-term in vitro ventricular assist (in vitro artificial heart) devices. Its products are used for the treatment and recovery of patients with cardiopulmonary bypass after cardiopulmonary bypass, as well as acute and acute conditions, such as fulminant myocarditis and cardiac arrest caused by acute diseases such as H1N1, severe car accidents, and drowning. The company was founded in 2016 and is based in Suzhou, China.

Picky

Pre Seed Round in 2021
Picky is a mobile-first community that enables consumers to discover the best skincare and beauty brands and products that are right for them through extensive user reviews, educational content, and experts’ contributions. With a focus on authenticity, education, and personalization, its community creates and consumes content about skincare and beauty, including K-beauty. Picky’s platform includes a Skin Type Analyzer, a one-minute tool that determines skin type with 14 easy questions. Based on the answers, users can discover the characteristics of their personal skin type and select what works best for them. The database, which is updated regularly, includes over 40,000 products from evergreen favorites to newly-launched indie K-beauty brands.

Diyi International Logistics

Venture Round in 2021
CNE invests in order to develop the sectors operational productivity, has developed an advanced integrated support service platform separately, and provides employment of automatic process sorting devices to attain an intelligent, efficient, and service company process. CNE has handled tens of thousands of cross-border e-commerce sellers and is the largest provider of inter-e-commerce logistics operations.

GiantMed Diagnostics

Venture Round in 2021
GiantMed Diagnostics is a third-party medical laboratory specializing in screening for unexplained eye diseases. It adheres to the concept of "patient-centered, providing comprehensive and high-quality testing services", it provides clinicians and patients with one-stop services for etiological testing, medical advice, a medical consultation, and scientific research cooperation.

VesiCURE Therapeutics

Venture Round in 2021
VesiCURE Therapeutics engages in the research and development of exosome innovative drugs. The company focuses on the research and development of exosomal (extracellular vesicles, EV) drugs, promoting the establishment and improvement of the exosomal pharmaceutical industry chain. The company was founded in 2021and is based in Suzhou, Jiangsu, China.

JAKA Biotech

Venture Round in 2021
JAKA Biotech is a cosmetic functional raw material manufacturer that provides superior skincare solutions. It aims to provide professional skincare solutions by focusing on the fields of plant extraction, fermentation, and synthesis. It was founded in 2010 and is based in MinHang District, Shanghai, China.

Novlead Biotech

Series A in 2021
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.

Genepoint Biological Technology

Venture Round in 2021
Genepoint Biological Technology (China) Co., Ltd. is a Shanghai-based company that specializes in the manufacturing of devices for cryogenic biomaterial storage and handling. Its product line includes Automated Cryo-Bio Storage systems, Plugged Hybrid Cryo-Storage units, LIN Vapor Freezers, and hoists designed for freezer operations. These products are primarily aimed at life sciences researchers, facilitating the safe and efficient storage of biological materials at low temperatures.

Applied Cells

Venture Round in 2021
Applied Cells creates a revolutionary solution to complete the workflow of cell separation and enrichment products. It helps in battles against cancer by providing tools that are not only capable of isolating the rarest cancer cells but also capable of extracting the highest quality immune cells to achieve better cell therapy outcomes. It was founded in 2017 and is based in Santa Clara, California.

Biobiggen

Venture Round in 2021
Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform. It is focusing on the pregnancy and childbirth period, focusing on prenatal screening, supplemented by newborn screening and prenatal diagnosis, and deeply creating the most complete high-throughput prevention and control of genetic diseases and birth defects Sequencing technology series of innovative products, leading enterprises and unicorn enterprises in the subdivision field. The company is headquartered in Beijing Economic and Technological Development Zone, has an overseas research center in Houston, the United States, and an R&D transformation center, GMP production base, and medical testing laboratory in Beijing.

SaintSages

Venture Round in 2021
SaintSages is a minimally invasive energy device enterprise. The company is headquartered in Shanghai, China.

Power Site

Venture Round in 2021
Power Site is a modern technology enterprise that supplies X-ray imaging core components. It mainly provides high-voltage generators (HVG), combined X-ray sources, power distribution units (PDU), and other core components overall solutions for X-ray imaging systems. The products are mainly used in high-end X-ray imaging systems such as CT, DR, mammography, C-arm, CBCT, security inspection, industrial inspection, etc. The company has an advanced and efficient manufacturing platform with an annual production capacity of 50,000 units.

GenFleet Therapeutics

Venture Round in 2021
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.

Yunyinggu

Series D in 2020
Yunyinggu Technology Co., Ltd. is a start-up company dedicated to developing and promoting new display technologies that can significantly improve the performance of flat panel displays. The company's proprietary solution is the world's best in achieving high PPI (pixel per inch) and can be applied to all kinds of flat panels such as LCD, LED, OLED and others. Yunyinggu Technology Co., Ltd. is based in China.

BSPK

Series A in 2020
BSPK, Inc. is a digital platform designed for luxury brands to personalize the shopping experience, boost sales, and enhance client retention. Founded in March 2017 by Zornitza Stefanova, the company is headquartered in Menlo Park, California. BSPK allows sales advisers to engage directly with customers through various channels, including brand websites, in-store interactions, mobile applications, and video streaming. By providing access to product images and sales data, BSPK aims to improve the overall client experience, fostering stronger connections between luxury brands and their customers.

BSPK

Series A in 2020
BSPK, Inc. is a digital platform designed for luxury brands to personalize the shopping experience, boost sales, and enhance client retention. Founded in March 2017 by Zornitza Stefanova, the company is headquartered in Menlo Park, California. BSPK allows sales advisers to engage directly with customers through various channels, including brand websites, in-store interactions, mobile applications, and video streaming. By providing access to product images and sales data, BSPK aims to improve the overall client experience, fostering stronger connections between luxury brands and their customers.

Brosmed

Series C in 2020
BrosMed Medical Co., Ltd. engages into medical equipment. The firm was founded in 2012 and is based in China.

Reworld

Series B in 2020
Reworld is a platform offering training and IT tools that allow users to design their own videogames.

MemVerge

Series B in 2020
MemVerge is delivering the world’s first Memory-Converged Infrastructure (MCI) system, built with proprietary Distributed Memory Objects (DMO) technology. DMO technology provides a logical convergence layer that harnesses Intel’s new Optane DC persistent memory to let data-centric workloads run flawlessly at memory speed.

TenaFe

Series A in 2020
TenaFe is a solid-state storage controller startup that develops revolutionary SSD for data storage solutions. Its patented technology, is transforming next generation solutions by powering unparalleled reliability, performance, and energy-efficient SSDs for a wide range of devices from connected gadgets to personal computers to data centers. TeneFe was founded in 2019 and is based in Campbell, CA.

Yunyinggu

Series C in 2020
Yunyinggu Technology Co., Ltd. is a start-up company dedicated to developing and promoting new display technologies that can significantly improve the performance of flat panel displays. The company's proprietary solution is the world's best in achieving high PPI (pixel per inch) and can be applied to all kinds of flat panels such as LCD, LED, OLED and others. Yunyinggu Technology Co., Ltd. is based in China.

BlueX Microelectronics

Series A in 2020
BlueX Microelectronics Corp. Ltd, a fabless semiconductor company, designs, develops, and markets ultra-low power wireless systems-on-chip and analog semiconductors for Internet of Things (IoT) and wearable applications. Its products are used in various applications, including IoT, wearable devices, consumer electronics, intelligent sports equipment, wireless medical, remote control, security, and toys. The company is based in Hefei, China.

Xinpletek

Series A in 2020
Xinpletek is a company based in Shanghai, China, that specializes in the design and development of radio frequency (RF) front-end solutions. The firm focuses on RF technology research and development, providing a range of RF front-end modules for applications in mobile phones, Internet of Things (IoT) devices, and intelligent terminals. Xinpletek's products are particularly relevant to 5G mobile communications, Narrowband IoT, and Wi-Fi technologies, catering to the growing demand for advanced wireless communication solutions.

Singular Medical

Series A in 2020
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.

Hugo Biotech

Series A in 2020
Hugo Biotech has conducted the sequencing of nearly 20,000 clinical samples for over 300 first class hospitals in china.

Boshi Medical

Venture Round in 2020
Boshi Medical engages in the research and development of ophthalmic medical devices. The company is headquartered in Nanjing, China.

HachiBot

Venture Round in 2020
HachiBot manufactures an intelligent quadruped robot for emotional companionship. Its robot can exist for human self-realization, provide users with company, let users feel love, and convey care. The company was founded in 2019 and is based in Chaoyang District, Beijing, China.

Multitude Therapeutics

Venture Round in 2020
Multitude Therapeutics develops drugs for the treatment of tumors. It focuses on developing novel antibody-drug conjugates (ADC), CAR-Ts, and immuno-oncology antibodies for solid and hematological tumors. MTX’s therapeutic programs are based on novel cancer and immune cell surface targets discovered by monoclonal antibody arrays (Human Membrane Proteome MabArrayTM or HMP-MabArrayTM) powered by the exceptional antibody discovery capabilities built at Abmart. The company was founded in 2018 and is based in Xuhui, Shanghai, China.

Polyvoly

Venture Round in 2020
Polyvoly is a beauty and personal care provider for the nourishment of the skin. It is designed and produces personal care products that are composed of essential oils and medicinal materials, enabling clients to nourish their skin and hair conditions. The company was founded in 2016 and is based in Wuhan, Hubei, China.

Belief Biomed

Venture Round in 2020
Belief Biomed brings the latest research achievements in precision medicine in Triangle area into production and promotes international collaboration by connecting established investors from China to explore the vast opportunity of North Carolina.

Sinovation Medical

Venture Round in 2020
Sinovation (Beijing) Medical Technology Co., Ltd. researches, develops, produces, and sells medical devices. The company is based in Beijing, China.

SMEC

Venture Round in 2020
SMEC provides foundry services focusing on technology solutions for power, connection, and sensor signal chain.

Yuanbao Insurance

Venture Round in 2020
Yuanbao Inc is a technology-driven online insurance distributor in China.

Bominwell Robotics

Series B in 2019
Shenzhen Bominwell Robotics Co., Ltd. designs and manufactures robots. It provides pipe inspection robots, such as wheeled military reconnaissance robots, crawler bomb disposal robots, and underground pipeline trajectory inertial navigation mapping robots, and pipe cloud platforms. The company also provides professional services, such as sonar detection, underwater detection, periscope detection, air-logged pipe issue, metamorphous pipe issue, and salty pipe issue detection services . Shenzhen Bominwell Robotics Co., Ltd. was founded in 2014 and is based in Shenzhen, China.

Micot

Seed Round in 2019
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.

Stellar Cyber

Series A in 2019
Stellar Cyber is an automated detection and response (Open-XDR) platform that correlates detections from existing solutions as well as its own security applications to deliver comprehensive protection across the cybersecurity kill chain and present them through one intuitive dashboard. Customers can leverage 20 native applications and a growing list of open ecosystem partners to detect and respond automatically to attacks within seconds wherever they occur on servers, in the network, at endpoints, or in cloud-based applications. Stellar Cyber deploys easily on premises, in public clouds or with service providers.

Yunyinggu

Series C in 2019
Yunyinggu Technology Co., Ltd. is a start-up company dedicated to developing and promoting new display technologies that can significantly improve the performance of flat panel displays. The company's proprietary solution is the world's best in achieving high PPI (pixel per inch) and can be applied to all kinds of flat panels such as LCD, LED, OLED and others. Yunyinggu Technology Co., Ltd. is based in China.

Qihan Biotech

Series A in 2019
Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation, and to solve the serious shortage of organ transplant donors in China and the world.
It provides mobile enterprise resource planning(ERP) systems for sales, production and storage management.

AgotoZ

Series B in 2019
AgotoZ Technology provides a network transmission intelligent platform with the capabilities of resource calculation and security defense. Established in 2017, Guanmai Technology (Beijing) Co., Ltd. is a leading WAN high-speed transmission core technology, big data computing technology, security defense technology, and accelerates its core technologies and products through independent research and development, focusing on providing high-speed and efficient enterprises. Interoperability platform and related solutions.

Huohua Logic

Series D in 2019
Huohua Siwei is an online education platform for K-12 children that specializes in Mathematics and Science. It offers a one-to-many online interactive live small class and strong interactive game links to develop students' core ability of thinking, concentration, and other core skills. It is focused on the young mathematics thinking training, which is divided into three modules: spatial thinking and graphics, computing power, and logical reasoning. The company was founded in 2017 and is headquartered in Beijing, China.
Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.

LuxCreo

Series B in 2019
Founded in 2016, LuxCreo is dedicated to large-scare 3D-printing manufacturing, covering software, hardware and materials.3D printing, often referred to as additive manufacturing, a process of building a 3-dimensional object by adding material layer by layer from a computer-aided design (CAD) model, has been a buzzword globally since 2011.

ServiceWall

Seed Round in 2019
ServiceWall is an e-commerce and financial scenario security service provider. It deploys front-end firewalls or post-data analysis services according to different business processes, mainly based on the local deployment of servers and software.

Xinpletek

Angel Round in 2019
Xinpletek is a company based in Shanghai, China, that specializes in the design and development of radio frequency (RF) front-end solutions. The firm focuses on RF technology research and development, providing a range of RF front-end modules for applications in mobile phones, Internet of Things (IoT) devices, and intelligent terminals. Xinpletek's products are particularly relevant to 5G mobile communications, Narrowband IoT, and Wi-Fi technologies, catering to the growing demand for advanced wireless communication solutions.